Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...

Please provide your email address to receive an email when new articles are posted on . The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced ...

"We need to find ways to engage frontline staff in the delivery of nonpharmaceutical interventions, including early preferred music, to achieve the goal of safe and effective management of ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Results from a Phase 3 clinical study for treatment of agitation in patients with Alzheimer’s dementia showed that patients treated with brexpiprazole had a statistically significantly greater ...

Medical and nursing students at the National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) will soon don virtual reality (VR) headsets to learn how to handle patients who ...

BioXcel Therapeutics Inc. announced this month that it has dosed its first patient in a Phase 3 study of its drug candidate for agitation in patients with Alzheimer’s disease. The study is evaluating ...

When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to ...

NDA submission supports the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home (outpatient) setting ...

Julieta* grew weaker as her illness progressed. She was a frail, 4'11", elderly woman battling terminal cancer who began punching the air, trying to assert control over an unfamiliar reality. As her ...

TOKYO & VALBY, Denmark--(BUSINESS WIRE)--Fifteenth paragraph of release should read: Brexpiprazole was discovered by Otsuka and is being co-developed by Otsuka and Lundbeck. The efficacy of ...